Refine
Year of publication
Document Type
- Preprint (595)
- Article (414)
- Conference Proceeding (2)
- Working Paper (2)
Has Fulltext
- yes (1013)
Is part of the Bibliography
- no (1013)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron scattering (experiments) (11)
- COVID-19 (8)
- Hadron-Hadron Scattering (6)
- Heavy-ion collision (5)
- SARS-CoV-2 (5)
- Non-small cell lung cancer (4)
- Quark-Gluon Plasma (4)
- Atmospheric chemistry (3)
- Collective Flow (3)
- Jets and Jet Substructure (3)
- B-cell lymphoma (2)
- Biomarkers (2)
- CV9202 (2)
- Chemotherapy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Germany (2)
- Heavy Quark Production (2)
- LHC (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Oncology (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Quarkonium (2)
- acute myeloid leukemia (2)
- cancer (2)
- computer-assisted (2)
- diversification (2)
- doxorubicin (2)
- drug release (2)
- epilepsy (2)
- hedonic (2)
- immunotherapy (2)
- index construction (2)
- influenza (2)
- lung cancer (2)
- out-patient paediatrics (2)
- poly(lactic-co-glycolic acid) (PLGA) (2)
- respiratory tract infection (2)
- targeted therapy (2)
- 900 GeV (1)
- ALICE (1)
- ALICE detector (1)
- ALK-rearranged NSCLC (1)
- APRI (1)
- ASCT (1)
- Accelerators & Beams (1)
- Acute myeloid leukemia (1)
- Advanced stage (1)
- Aedes aegypti (1)
- Ag-RDT (1)
- Altenberg–Teplice Volcanic Complex (1)
- Anopheles stephensi (1)
- Anti-nuclei (1)
- Antibody therapy (1)
- Artificial Intelligence (1)
- Atomic, Molecular & Optical (1)
- B-cell immunology (1)
- BATF3 (1)
- BCOR (1)
- BCORL1 (1)
- BI1361849 (1)
- Bamlanivimab (1)
- Biodiversity (1)
- Biodiversity Data (1)
- Biogeochemistry (1)
- Biogeography (1)
- Biomarker (1)
- Biomonitoring (1)
- Bloodstream infections (1)
- Bodenpreis (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Box-Cox transformation (1)
- Box-Cox-Transformation (1)
- Brain tumor (1)
- CA-ID-TIMS zircon dating (1)
- CHIP (1)
- COVID‐19 (1)
- CTLA-4 (1)
- Cancer (1)
- Cancer genomics (1)
- Carboniferous volcanism (1)
- Casirivimab (1)
- Cave fish (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charged-particle multiplicity (1)
- Chemicals of emerging concern (1)
- Chemistry (1)
- Chocó rainforest (1)
- Chondral Lesion (1)
- Climate-change impacts (1)
- Clinical Trials and Observations (1)
- Clinical trial (1)
- Cohort studies (1)
- Comparative analysis (1)
- Complicated stage (1)
- Conservation (1)
- Deep neural network (1)
- Digitization (1)
- Drug resistance/synergy (1)
- E3 Ligase (1)
- EGFR (1)
- EP300 (1)
- EWSR1 (1)
- Ecotoxicology (1)
- Ecuador (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Endothelial cells (1)
- Environmental quality (1)
- Epidemiology (1)
- Erzgebirge (1)
- Evidence-based guidelines (1)
- Extended donor criteria (1)
- Extremophile teleosts (1)
- FIB-4 (1)
- FOXO1 (1)
- Fibre/foam sandwich radiator (1)
- Fisheries (1)
- Forschung (1)
- Gene fusion (1)
- Geschichte 1990-1999 (1)
- Glioma (1)
- Gradient boosting (1)
- Graft function (1)
- Graft survival (1)
- Gram negative bacteria (1)
- HBV (1)
- HNO (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Heavy Ion Experiment (1)
- Hedonischer Preis (1)
- Hematopoietic stem cell transplantation (1)
- Herbaria (1)
- Hodgkin lymphoma (1)
- Hypofractionated radiotherapy (1)
- IAP (1)
- Image processing (1)
- Imdevimab (1)
- Immobilien-Investment (1)
- Immobilienmarkt (1)
- Immunomonitoring (1)
- Incidence (1)
- Index (1)
- Indexzahl (1)
- Intensive care units (1)
- Intervertebral disc displacement (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jets (1)
- LEOSS (1)
- LVSPE (1)
- Lafora disease (1)
- Lehre (1)
- Litter (1)
- Liver transplantation (1)
- Lockstoffe (1)
- Low-dose X-irradiation (1)
- Lung Cancer (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- MEDIC (1)
- MRI (1)
- MTCL (1)
- Machine learning (1)
- Marginal grafts (1)
- Material budget (1)
- Medication Appropriateness Index (1)
- Mengenindex (1)
- Microplastics (1)
- Micropollutants (1)
- Minimum Bias (1)
- Mitosis (1)
- Mixture risk assessment (1)
- Molecular diagnostic testing (1)
- Molecular matched therapy (1)
- Molecular profiling (1)
- Monitoring (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-syndrome classification (1)
- Multi-wire proportional drift chamber (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- Myeloid Neoplasia (1)
- Mückenmonitoring (1)
- NanoBRET (1)
- Nanoparticles (1)
- Neural network (1)
- Neuroblastoma (1)
- Neurodegenerative syndromes (1)
- Neuroepithelial tumor (1)
- Neutropenia (1)
- Nivolumab (1)
- Non-small-cell lung cancer (1)
- Non–small-cell lung cancer (1)
- ORL (1)
- Observational study (1)
- Organ rinse (1)
- Organ shortage (1)
- Osimertinib (1)
- Otorhinolaryngology (1)
- Overall survival (1)
- Overcompensation (1)
- PCR (1)
- PD-1 (1)
- PDEs (1)
- PEGylated PLGA (PLGA-PEG) (1)
- PLAGL1 (1)
- POCT (1)
- PROTAC (1)
- PYTHIA (1)
- Palaeontology (1)
- Paris (1)
- Particle and Resonance Production (1)
- Patellofemoral Joint (1)
- Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (1)
- Pb–Pb collisions (1)
- Plastics (1)
- Poecilia mexicana (1)
- Polarization (1)
- Polymers (1)
- Predictive model (1)
- Preisindex (1)
- Production Cross Section (1)
- Prognosis (1)
- Prognostic markers (1)
- Properties of Hadrons (1)
- Psoriasis vulgaris (1)
- QCD (1)
- QSARs (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- RNA dynamics (1)
- RNActive (1)
- ROS (1)
- ROS1 (1)
- Radiation detectors (1)
- Random forest (1)
- Rapidity Range (1)
- Real estate investments (1)
- Real-world data (1)
- Registries (1)
- Relativistic heavy-ion collisions (1)
- Research (1)
- Research Infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Review (1)
- Risk drivers (1)
- River pollution (1)
- Rotenone (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SMAD (1)
- SOD (1)
- STIR (1)
- Schätzung (1)
- Semantics (1)
- Sexual selection (1)
- Small-cell lung cancer (1)
- Specialist training (1)
- Spine (1)
- Stegomyia aegypti (1)
- Stenotrophomonas maltophilia (1)
- Support vector machine (1)
- Supratentorial (1)
- Surface waters (1)
- Systematic Uncertainty (1)
- T cell/histiocyte rich large B cell lymphoma (1)
- T-cell homeostasis (1)
- T-cell niche (1)
- TGFβ (1)
- TP53 mutation status (1)
- TR (1)
- Tacrolimus (1)
- Target screening (1)
- Targeted therapy (1)
- Taxonomy (1)
- Teaching (1)
- Thermodynamics (1)
- Thrombotic microangiopathy (1)
- Thrombotic thrombocytopenic purpura (1)
- Time Projection Chamber (1)
- Tomography (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Treatment (1)
- Trigger (1)
- Tumour biomarkers (1)
- Ubiquitin (1)
- University hospitals (1)
- Universitätskliniken (1)
- Upper crustal magmatic system (1)
- Variscan belt (1)
- Vector Boson Production (1)
- Viral load (1)
- Water framework directive (1)
- Weiterbildung (1)
- Wohnungsmarkt (1)
- X-ray computed (1)
- Xenon-based gas mixture (1)
- YK-4-279 (1)
- aboveground biomass (1)
- acoustic radiation force impulse imaging (1)
- advanced melanoma (1)
- amygdalin (1)
- analgesia (1)
- anti-angiogenic therapy (1)
- anticonvulsants (1)
- attractants (1)
- atypical EGFR mutations (1)
- autologous stem cell transplantation (1)
- autophagy (1)
- bioactivity testing (1)
- biodiversity (1)
- bortezomib (1)
- box-cox transformation (1)
- brain metastases (1)
- cBioPortal (1)
- cabazitaxel (1)
- cabozantinib (1)
- calcium dynamics (1)
- caspase-1 (1)
- cell culture (1)
- cerebral pseudoprogression (1)
- chemotherapy (1)
- chronosequence (1)
- clinical (1)
- clonal dominance (1)
- clonal hematopoiesis (1)
- coarse-grained simulations (1)
- complementary/alternative medicine (CAM) (1)
- complete response (1)
- computational biology (1)
- computer-assisted drug therapy (1)
- cytarabine dose (1)
- dE/dx (1)
- data science (1)
- decision making (1)
- decision support systems (1)
- detailed modeling (1)
- detector (1)
- diffuse large B cell lymphoma (1)
- discontinuation (1)
- disease progression (1)
- docetaxel (1)
- easyPACId (1)
- ectosomes (1)
- elderly (1)
- electrical stimulation (1)
- emulsion diffusion (1)
- epileptic encephalopathies (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- female choice (1)
- fibrotest (1)
- gene expression profiling (1)
- gene signature (1)
- gene therapy (1)
- genetics (1)
- germinal center (1)
- glioblastoma (1)
- guanidine-II riboswitch (1)
- guidelines (1)
- head and neck squamous cell carcinoma (1)
- head-and-neck cancer (1)
- healthcare systems (1)
- heavy ion experiments (1)
- hedonische Indizes (1)
- hematopoietic stem cells (1)
- hematopoietic stress (1)
- high sensitive C-reactive protein (1)
- host response (1)
- human pain models (1)
- human pharmacology (1)
- hybrid (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitors (ICI) (1)
- immune related adverse events (irAE) (1)
- induction regimen (1)
- infectivity (1)
- inflammation (1)
- inpatient hospital admissions (1)
- interleukin-1beta (1)
- juvenile myoclonic epilepsy (1)
- kidney (1)
- lenalidomide (1)
- leukemia (1)
- levetiracetam (1)
- liver metastasis (1)
- local radiotherapy (1)
- lockdown (1)
- logistic models (1)
- loss-of-function (1)
- lymphoma pathogenesis (1)
- mRNA active cancer immunotherapy (1)
- mRNA vaccine (1)
- machine learning (1)
- macrophage polarization (1)
- mature T-cell lymphoma (1)
- medical informatics initiative (1)
- medication reconciliation (1)
- metastasis (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- molecular tumor board (1)
- mosquito monitoring (1)
- multimorbidity (1)
- multiple chronic conditions (1)
- multiple myeloma (1)
- nanoparticles (1)
- natural products (1)
- neoplasms (1)
- neurological complication (1)
- neurological manifestations (1)
- neurological side effects (1)
- neuron (1)
- neutralizing antibodies (1)
- nocardia (1)
- nocardiosis (1)
- nodular lymphocyte predominant Hodgkin lymphoma (1)
- non-independent mate choice (1)
- non-invasive fibrosis assessment (1)
- non-small cell lung cancer (1)
- non-small-cell lung cancer (1)
- ntracellular signaling (1)
- oncogene (1)
- p+p collisions (1)
- pain (1)
- pandemic (1)
- parallel (1)
- pharmacoresistance (1)
- platelets (1)
- point shear wave elastography (1)
- polylactic acid (PLA) (1)
- polypharmacy (1)
- postoperative radiochemotherapy (1)
- postoperative radiotherapy (1)
- precision medicine (1)
- predator recognition (1)
- progressive myoclonus epilepsy (1)
- propensity score matching (1)
- prostate cancer (1)
- proteobacteria (1)
- proteomics (1)
- pulmonary nocardiosis (1)
- quark gluon plasma (1)
- real estate investments (1)
- reassembly (1)
- renal failure (1)
- reproducibility (1)
- requirements analysis (1)
- resilience (1)
- resistance (1)
- resistant cell lines (1)
- riboswitch (1)
- rigor (1)
- risk factors (1)
- risk stratification (1)
- second-line immunotherapy (1)
- seizure (1)
- sequential ALK-inhibitor therapy (1)
- simplified production (1)
- single-molecule FRET (1)
- solvent displacement (1)
- somatic mutations (1)
- spike protein (1)
- standardization (1)
- survival (1)
- therapy resistance (1)
- transient elastography (1)
- treatment resistance (1)
- trees (1)
- tumor angiogenesis (1)
- tumor microenvironment (1)
- university hospitals (1)
- uveal melanoma (1)
- variants of concern (1)
- γH2AX (1)
Institute
Deuterons are atomic nuclei composed of a neutron and a proton held together by the strong interaction. Unbound ensembles composed of a deuteron and a third nucleon have been investigated in the past using scattering experiments and they constitute a fundamental reference in nuclear physics to constrain nuclear interactions and the properties of nuclei. In this work K+−d and p−d femtoscopic correlations measured by the ALICE Collaboration in proton−proton (pp) collisions at s√=13 TeV at the Large Hadron Collider (LHC) are presented. It is demonstrated that correlations in momentum space between deuterons and kaons or protons allow us to study three-hadron systems at distances comparable with the proton radius. The analysis of the K+−d correlation shows that the relative distances at which deuterons and proton/kaons are produced are around 2 fm. The analysis of the p−d correlation shows that only a full three-body calculation that accounts for the internal structure of the deuteron can explain the data. In particular, the sensitivity of the observable to the short-range part of the interaction is demonstrated. These results indicate that correlations involving light nuclei in pp collisions at the LHC will also provide access to any three-body systems in the strange and charm sectors.
Measurements of (anti)proton, (anti)deuteron, and (anti)3He production in the rapidity range −1<y<0 as a function of the transverse momentum and event multiplicity in p-Pb collisions at a center-of-mass energy per nucleon-nucleon pair sNN−−−√=8.16 TeV are presented. The coalescence parameters B2 and B3, measured as a function of the transverse momentum per nucleon and of the mean charged-particle multiplicity density, confirm a smooth evolution from low to high multiplicity across different collision systems and energies. The ratios between (anti)deuteron and (anti)3He yields and those of (anti)protons are also reported as a function of the mean charged-particle multiplicity density. A comparison with the predictions of the statistical hadronization and coalescence models for different collision systems and center-of-mass energies favors the coalescence description for the deuteron-to-proton yield ratio with respect to the canonical statistical model.
The invariant differential cross sections for inclusive π0 and η mesons at midrapidity were measured in pp collisions at s√=2.76 TeV for transverse momenta 0.4<pT<40 GeV/c and 0.6<pT<20 GeV/c, respectively, using the ALICE detector. This large range in pT was achieved by combining various analysis techniques and different triggers involving the electromagnetic calorimeter (EMCal). In particular, a new single-cluster, shower-shape based method was developed for the identification of high-pT neutral pions, which exploits that the showers originating from their decay photons overlap in the EMCal. Above 4 GeV/c, the measured cross sections are found to exhibit a similar power-law behavior with an exponent of about 6.3. Next-to-leading-order perturbative QCD calculations differ from the measured cross sections by about 30% for the π0, and between 30–50% for the η meson, while generator-level simulations with PYTHIA 8.2 describe the data to better than 10–30%, except at pT<1 GeV/c. The new data can therefore be used to further improve the theoretical description of π0 and η meson production.
The Transition Radiation Detector (TRD) was designed and built to enhance the capabilities of the ALICE detector at the Large Hadron Collider (LHC). While aimed at providing electron identification and triggering, the TRD also contributes significantly to the track reconstruction and calibration in the central barrel of ALICE. In this paper the design, construction, operation, and performance of this detector are discussed. A pion rejection factor of up to 410 is achieved at a momentum of 1 GeV/c in p–Pb collisions and the resolution at high transverse momentum improves by about 40% when including the TRD information in track reconstruction. The triggering capability is demonstrated both for jet, light nuclei, and electron selection.
The invariant differential cross sections for inclusive π0 and η mesons at midrapidity were measured in pp collisions at s√=2.76 TeV for transverse momenta 0.4<pT<40 GeV/c and 0.6<pT<20 GeV/c, respectively, using the ALICE detector. This large range in pT was achieved by combining various analysis techniques and different triggers involving the electromagnetic calorimeter (EMCal). In particular, a new single-cluster, shower-shape based method was developed for the identification of high-pT neutral pions, which exploits that the showers originating from their decay photons overlap in the EMCal. The measured cross sections are found to exhibit a similar power-law behavior with an exponent of about 6.3. Next-to-leading order perturbative QCD calculations and generator-level simulations with PYTHIA 8.2 describe the cross sections to about 30% for the π0, and between 30-50% for the η meson. The new data can therefore be used to further improve the theoretical description of π0 and η meson production.
The invariant differential cross sections for inclusive π0 and η mesons at midrapidity were measured in pp collisions at s√=2.76 TeV for transverse momenta 0.4<pT<40 GeV/c and 0.6<pT<20 GeV/c, respectively, using the ALICE detector. This large range in pT was achieved by combining various analysis techniques and different triggers involving the electromagnetic calorimeter (EMCal). In particular, a new single-cluster, shower-shape based method was developed for the identification of high-pT neutral pions, which exploits that the showers originating from their decay photons overlap in the EMCal. The measured cross sections are found to exhibit a similar power-law behavior with an exponent of about 6.3. Next-to-leading-order perturbative QCD calculations differ from the measured cross sections by about 30% for the π0, and between 30-50% for the η meson, while generator-level simulations with PYTHIA 8.2 describe the data to better than 10-30%, except at pT<1 GeV/c. The new data can therefore be used to further improve the theoretical description of π0 and η meson production.
The Transition Radiation Detector (TRD) was designed and built to enhance the capabilities of the ALICE detector at the Large Hadron Collider (LHC). While aimed at providing electron identification and triggering, the TRD also contributes significantly to the track reconstruction and calibration in the central barrel of ALICE. In this paper the design, construction, operation, and performance of this detector are discussed. A pion rejection factor of up to 410 is achieved at a momentum of 1 GeV/c in p-Pb collisions and the resolution at high transverse momentum improves by about 40% when including the TRD information in track reconstruction. The triggering capability is demonstrated both for jet, light nuclei, and electron selection.
The production of muons from heavy-flavour hadron decays in p-Pb collisions at sNN−−−√=5.02 TeV was studied for 2<pT<16 GeV/c with the ALICE detector at the CERN LHC. The measurement was performed at forward (p-going direction) and backward (Pb-going direction) rapidity, in the ranges of rapidity in the center-of-mass system (cms) 2.03<ycms<3.53 and −4.46<ycms<−2.96, respectively. The production cross sections and nuclear modification factors are presented as a function of transverse momentum (pT). At forward rapidity, the nuclear modification factor is compatible with unity while at backward rapidity, in the interval 2.5<pT<3.5 GeV/c, it is above unity by more than 2σ. The ratio of the forward-to-backward production cross sections is also measured in the overlapping interval 2.96<|ycms|<3.53 and is smaller than unity by 3.7σ in 2.5<pT<3.5 GeV/c. The data are described by model calculations including cold nuclear matter effects.
The production of muons from heavy-flavour hadron decays in p-Pb collisions at sNN−−−√=5.02 TeV was studied for 2<pT<16 GeV/c with the ALICE detector at the CERN LHC. The measurement was performed at forward (p-going direction) and backward (Pb-going direction) rapidity, in the ranges of rapidity in the center-of-mass system (cms) 2.03<ycms<3.53 and −4.46<ycms<−2.96, respectively. The production cross sections and nuclear modification factors are presented as a function of transverse momentum (pT). At forward rapidity, the nuclear modification factor is compatible with unity while at backward rapidity, in the interval 2.5<pT<3.5 GeV/c, it is above unity by more than 2σ. The ratio of the forward-to-backward production cross sections is also measured in the overlapping interval 2.96<|ycms|<3.53 and is smaller than unity by 3.7σ in 2.5<pT<3.5 GeV/c. The data are described by model calculations including cold nuclear matter effects.